Inflammation Research 2002: Vol 51 Index

7 Pages·2002·1.2 MB·English

Inflammation
Research
Author Index
Abe, Y., 483 Coletta, I., 252 Geng, J.-G., 435 Kaltwasser, J. P., 457
Adamashvili, I., 290 Collis, M., 464 Gerwick, W. H., 112 Kast, R. E., 117
Adcock, I., 479 Connolly, N. C., 579 Getting, S. J., 110 Kaszaki, J., 511
Ahnfehit-Ronne, I., 423 Coppola, D., 522 Gibbs, L., 300 Katchur, S. R., 85
Aikawa, Y., 188 Costa, C. H. S., 144 Gil Marqués, G., 587 Katori, M., 324
Alarcon de la Lastra, C., 51, Coulson, F. R., 317 Gonzalez, R., 351 Katrib, A., 170
385 Cui, P, 195 Goppelt-Struebe, M., 568 Kessler, U., 457
Altdorfer, K., 569 Cunha, F Q., 144 Grace, K., 112 Khalil, Z., 295
Andermahr, J., 265 Grapenthin, S., 457 Khodr, B., 295
Anderson, R., 594 D'Onofrio, E., 252 Greb, A., 265 Kido, H., 195
Aquilini, L., 252 Da Silva-Santos, J. E., 377 Griffiths, R., 77 Kim, K. C., 490
Arthur, H. M., 464 Daffonchio, L., 223 Grimbaldeston, M. A., 236 Kitamura, H., 195
Assreuy, J., 377 Dagtekin, G., 403 Grip, 0., 58 Kiyohara, T., 409
Azghani, A. O., 506 Damazo, A. S., 300 GrGnneberg, R., 532 Klein, S. A., 457
Danihelova, E., 557 Guglielmotti, A., 252 Kleine, P., 363
Bacciottini, L., 259 Davio, C., 1 Guyton, S. W., 579 Ko, K. H., 490
Bagameéri, G., 569 Davis, R. J., 80 Koch, K., 77
Baker, J. W., 506 De Brum-Fernandes, A. J., 24 Habernickel, J., 33 Koerber, K., 229
Baldi, A., | de Jager, S.C. A., 63 Hall, A. R., 579 Kohno, S., 206
Balogh, A., 511 de Souza, G. E. P., 24 Hanselmann, R. G., 416 Kolaczkowska, E., 519
Baron, J., 403 Deckblatt, C., 69 Hansen, U., 563 Kolls, J., 102
Baronti, R., 259 Delaney, S., 110 Hart, P. H., 236, 283 Komai, M., 307
Befus, A. D., 45] Delecata, R. J., 213 Hartner, A., 568 Kool, M., 63
Bertuglia, S., 223 Dominguez Fernandez, E., 500 Hartung, T., 119 Koshino, T., 357
Bhat, G. J., 506 Donath, T., 569 Hayashi, T., 357 Koyama, N., 457
Bigg, C. S., 317 Dong, C., 80 eC, S72 Kranefeld, A. D., 63
Blobel, C. P, 83 Dosogne, H., 20] Helling, H.-J., 265 Kristensen, J. K., 563
Bokarewa, M. I., 471 Drabikova, K., 557 Hendel, J., 423 Kukoc-Zivojnov, N., 457
Bolognese, B. J., 85 Drew, J., 236 Henrich, D., 363 Kulka, M., 45]
Boneberg, E.-M., 119 Duda, D., 495 Hensler, T., 265 Kuriyama, K., 483
Boros, M., 511 Duda, E., 511 Herrerias, J. M., 51, 385 Kuwabara, K., 541]
Bouillon, B., 265 Dyer, R. D., 71 Heywood, G. J., 176
Brain, S. D., 295 Dzemali, O., 363 Hiemstra, P. S., 8 Laufer, §., 129, 135
Brand, C., 236, 283 Hill, M. E., 579 Lausberg, H. F.,, 416
Breddin, H. K., 129 Eichler, A., 416 Hoelzer, D., 457 Lawrence,T. , 108
Brunner, N., 563 Evans, C. H., 342 Holmes, J. H., 579 Lazar, G., 511
Brune, K., 568 Hori, Y., 541 Lazar, G. J., 511
Buckbinder, L., 167 Fabricio, A. S. C., 24 Horiguchi, T., 483 Lee, C. J., 490
Buelow, R., 522 Faller, A., 85 Hu, G., 332 Lemos, B., 1
Burt, H. M., 105 Fehér, E., 569 Huang, Y., 332 Lindgren, S., 58
Burvenich, C., 20) Feng, M., 332 Hussien, M., 213 Liu, Q., 182
Fernandes, D., 377 Liu, Q., 245
Cabré, F., 51 Fernandez, V., 351 Inushima, K., 160 Lohschiitz, D., 416
Calixto, J. B., 603 Fernvik, E., 245 Irie, K., 38 Lojek, A., 557
Cao, J. S., 44 Ferreira, S. H., 24, 144 Ishida, H., 38 Lopes, M. C., 369
Cao, T., 295 Finlay-Jones, J. J., 236, 283 Ishida, S., 611 Lora, M., 24
Capper, E. A., 112 Flamberg, P. L., 85 Iwamura, H., 160 Lorenz, W., 495
Caramona, M. M., 369 Flanigan, A., 522 Lubberts, E., 102
Cardoso, R. A., 24 Flavell, R. A., 80 Jackson, J. K., 105 Lundahl, J., 245, 532
Carey, P. D., 213 Fleisch, J. H., 541 Jacobs, R. S., 112
Carollo, M., 110, 300 Flohé, S., 500 Jahnen-Dechent, W., 403 Majima, M., 324
Carpenter, G., 91 Folkerts, G., 33 Janciauskiene, S., 58 Mannaioni, P. F., 259
Carvalho, A. P., 369 Fraser, P. A., 290 Jennewein, M., 416 Mannesse-Lazeroms,
Celik, I., 495 Fredriksson, K., 245 Jin, Y., 332 S.P.G.,8
Charlton, R., 464 Fujii, E., 38 Jochem, J., 551 Marolewski, A. E., 85
Chen, Q., 332 Joosten, L.A. B., 102 Marquéz, B., 112
Chen, X.-C., 444 Gamble, J. R., 236 Jyoyama, H., 541 Marshall, L. A., 85, 112
Christensen, I. J., 563 Gao,Y. ,3 32 Martin, M. J., 51, 385
Christie, M. I., 110 Gebel, H., 290 Kakutani, M., 160 Martinez-Mir, I., 587
Ciz, M., 587 Geisslinger, G., 393 Kalina, U., 457 Masini, E., 259
Massart-Leén, A. M., 201 Oliveira, S. H. P., 144 Soltés, L., 115 Winkler, J. D., 76
Masuda, T., 307 Ortiz, P., 385 Steel, H. C., 594 Wirtschafter, J. D., 16
Matheis, G., 363 Ottmann, O. G., 457 Steinmeyer, J., 427 Wooley, P. H., 342
Matsuzawa, Y., 409 Ozawa, S., 611 Stevenson, C. S., 112 Wu, B., 342
Mayer, R. J., 85 Stridh, H., 532 Wu, C., 332
Mayton, L., 342 Pahl, A., 273, 568 Sturk, A., 201
McDonald, J. C., 290 Pahl, S., 416 Su, M., 572 Xu, Q., 44, 444
McLoon, L. K., 16 Paik, S. H., 490 Suganuma, T., 38
McNeil, H. P., 170 Parums, D., 464 Svendsen, M. N., 563 Yamamoto, M., 188
Meller, S. T., 393 Paszt, A., 511 Swanson, S. J., 572 Yamamoto, T., 188
Melo, M. C. C., 24 Paull, D. L., 579 Szakacs, J., 511 Yang, S., 342
Mendes, A. FE, 369 Peretti, M., 110 Szelenyi, I., 273 Yano, M., 195
Mendichi, R., 115 Perretti, M., 300 Yoshioka, T., 38
Mentzer, S. J., 572 Peterson, L. J., 563 Takagi, M., 324 Young, A. J., 572
Meyer, E., 201 Pinardi, G., 219 Takagi, T., 357 Youssef, P. P., 170
Milanese, C., 252 Pinheiro, R. M., 603 Takahashi, Y., 307
Milford, E. L., 290 Pini, L. A., 154 Takakura, R., 409 Zampronio, A. R., 24
Miller, E. J., 506 Pinza, M., 252 Takenaka, H., 206 Zhang, X. M., 44
Miranda, H. F, 219 Postma, D. S., 33 Takeuchi, K., 160 Zhao, T., 572
Miyazaki, Y., 409 Pressly, T., 290 Tanaka, H., 307, 188 Zhou, J., 91, 332,
Miyoshi, Y., 409 Tanimoto, M., 357 Zhu, H.-S., 435
Mizutani, N., 206 Radziwon, P., 129 Tapia, G., 351 Zibari, G., 290
Mladovan, A., | Rae, G. A., 24 Tarkowski, A., 471 Ziegler, S. F., 579
Moller, B., 457 Rehm, K. E., 265 Tegeder, I., 393 Zimmermann, J., 393
Monczor, F., 1 Remirez, D., 351 Terada, T., 206 Zwadlo-Klarwasser, G., 403
Moraies-Olivas, F. J., 587 Rennard, S. I., 245 Teshima, R., 611
Morimoto, K., 188 Rivera, E., 1 Theron, A. J., 594
Morissey, J., 471 Robbins, P. D., 342 Thomas, P. S., 176
Moritz, A., 363 Roshak, A. K., 112 Thorlacius, H., 182
Motilva, V., 51, 385 Rubio-Gomis, E., 587 Tiegs, G., 229
Mu, J.-S., 435 Tintinger, G, R., 594
Muijsers, R. B. R., 33 Sadowski, T., 427 Tiszlavisez, L., 511
Muraki, T., 38 Saito, M., 324 Tokuoka, S., 307
Murata, E., 195 Saito, T., 357 Torsney, E., 464
Murayama, Y., 409 Saito, Y., 611 Townley, S. L., 283
Murthy, S., 76, 522 Sanchez, S., 385 Tries, S., 129, 135
Mutschler, W., 416 Sandnas, A. M., 16 Tudan, C., 105
Sandrini, M., 154
Nabe, T., 206 Sass, G., 229 van de Loo, F A. J., 102
Nagai, H., 307 Sauerland, S., 265 van den Berg, W. B., 102
Nagao, K., 307 Sawada, J., 611 van der Veeken, A., 33
Nakamura, R., 611 Schade, F. U., 500 van Heuven-Nolsen, D., 63
Nau, M., 500 Schiffer, R., 403 van Houwelingen, A. H., 63
Neugebauer, E., 265 Scholz, M., 363 van Loon, J., 201
Neupert, W., 135 Schwarzenberger, P., 102 van Sterkenburg,
Nielsen, H. J., 563 Schwingshackl, A., 451 M.A. J.A., 8
Nielsen, O. H., 423 Sharmin, S., 195 van Wetering, S., 8
Nieto, A., 51 Shayo, C., 1 Videla, L. A., 351
Nijkamp, F. P., 33, 63 Shetty, S., 506 Vitale, G., 154
Nockleby, K. J., 16 Shima, C., 324
Nopp, A., 532 Shimizu, T., 483 Wakitani, K., 160
Nosal, R., 557 Shinomura, Y., 409 Wan, M. X., 182
Novellini, R., 223 Shiota, M., 195 Wang, H., 332
Siemers, F., 500 Wang, J.-G., 435
O'Donnell, S. R., 317 Sierralta, F., 219 Wang, Y.,. 182
Oberringer, M., 416 Silva, V. M. S., 24 Watabe, M., 483
Ogawa, R., 38 Simon, A., 363 Werther, K., 563
Ogino, M., 324 Sittig, K., 290 West, C. A., 572
Okunuki, H., 611 Skéld, C. M., 245 White, B., 73
Oliani, S. M., 300 Smith, D. G., 85 Wimmer-Greinecker, G., 363
Subject Index
Acarbose, 117 Cell proliferation, 112 G-CSF receptor, 119
Acute lung injury, 160 Centrosome hyperamplification, 416 Gadolinium chloride, 511
ADAMs, 83 Chemiluminescence, 557 Galactosamine (GalN)/TNF hepatitis,
Adenosine, 594 Chloride channels, 451 229
Adenosine deaminase, 594 Chondrocyte, 369, 427 Gastric sparing, 135
Adjuvant arthritis, 252 Chronic inflammation, 110 Gastric ulcer, 51
Aggregation, 557 CINC-1, 160 Gene expression, 611
Air-pouch, i110, 300 Coliform mastitis, 201 Gene expression profile, 332
Airway, 490 Colitis, 182 Gene therapy, 102
Airway epithelial cells, 8 Colonic specimens, 423 Gene transfer, 342
Airway inflammation, 307 Complement, 579 Glucocorticoids, 38
Airway responsiveness, 33 Contact dermatitis, 483 Glutamate, 393
Allergic rhinitis, 206 Contact Hypersensitivity, 236 GM-CSF, 532
Alpha-adrenoceptors, 219 Corticosteroids, 457 Goblet, 490
Amphotericin B, 259 CPPD crystal, 105 Goblet cells, 307
Angiogenesis, 464, 563 Cardiac surgery , 363 Gouty arthritis, 105
Animal model, 108 Crohn's disease, 117, 423 Granuloma, 300
Anti-asthmatic strategies, 273 Cyclic AMP, 594 Growth factor, 91
Anti-rheumatic agent, 188 Cyclooxygenases (COXs), 24 Guanylate cyclase, 377
Antifungal agents, 213 COX / 5-LOX inhibitor, 129
Antigen-induced arthritis, 541 COX-expression, 51 Haemorrhagic hypotension, 551
Antihistamines, 495 Cytokine inhibitor, 160 Hamster cheek pouch microcirculation,
Antiinflammatory, 135 Cytokine/ chemokine inhibitors, 273 223
Antinociception, 154 Cytokines, 8, 102, 170, 188, 403, 506 Heat shock protein, 108
Antioxidant, 611 Cytoprotective proteins, 229 Hepatocytes, 444
Antithrombotic effects, 129 Hepatotoxicity, 44
Apoptosis, 105, 444, 532 Defensins, 8 Heregulin, 91
Arachidonic acid, 423 Delayed-type hypersensitivity, 44 HHT, 464
Arrhythmias, 495 DesArg9Leu8BK, 295 High dose levels, 483
Arthritis, 471 Desensitization, 587 High-affinity IgE receptor, 611
Aspirin, 129 Dexamethasone, 8 Histamine, 283, 557
Asthma, 176 Dextran, 572 Histamine exudation, 324
Atorvastatin, 58 Dextran sulphate-induced colitis, 522 Histamine H2-receptor, 587
Autoimmunity, 102 Diclofenac, 219 Histamine release, 495
AVP, 24 Dinitrofluorobenzene, 63 Histamine-2 receptor antagonist, 563
Dipyrone, 24 HOE 140, 295
Basophils, 259 Dithiaden, 557 5-HT levels, 154
Bile, 500 DNA microarray, 611 5-HT2 receptors, 154
Biliary obstruction, 511 Human breast epithelial cells, 1
Blood flow, 572 Efficacy of RDP 58 in colitits, 522 HUVECs, 332
Bradykinin, 223, 295 ELISA, 110, 290 Hyperresponsiveness, 206
Bronchial asthma, 273 Endogenous histamine, 551 Hypersensitivity reaction, 63
Bronchial cells, 416 Endothelin, 195 Hypochlorous acid, 213
Bronchial hyperresponsiveness, 307 Endotoxin pretreatment , 500
Endotoxin resorption, 201 ICAM-1, 44
C-fos, | Enrofloxacin treatment, 201 IgE, 85, 206
C-mryc, | Eosinophil, 195 IkappaBalpha, 188
C-phycocyanin, 351 Eosinophil migration, 144 Immune response, 403
Calcium, 594 Eotaxin, 195 Immuno-allergic reactions, 259
Candidaemia, 213 ErbB-4, 91 Immunocytochemistry, 569
Cardiopulmonary bypass, 579 Erythrocyte, 245 Increased vascular permeability, 324
Caraiovascular regulation, 551 Experimental colitis, 569 Indomethacin, 24
Carrageenan, 603 Extracellular matrix, 245 Inflammation, 33, 58, 63, 108, 112, 117,
Carrageenin pleurisy, 324 119, 170, 252, 342, 377, 435, 464,
Caspase 3, 532 Factor VII, 471 471, 579, 603
CD23, 85 Fever, 24 Inflammatory bowel disease, 409, 423
CD4 T lymphocytes, 444 Fibrinogen, 324 Inflammatory targets, 273
CD40, 409 Fibronectin, 245 Interleukin-1 (IL-1), 102
CD69, 532 Fibrosis, 245 Interleukin-1 receptor antagonist (IL-RA),
cDNA array, 332 Fluorescent dye, 572 342
Celecoxib, 603 Fungaemia, 213 Interleukin-1 beta, 223, 369
Cell culture, 416 Interleukin-5 (IL-5), 195
Interleukin-8 (IL-8), 144 Nicorandil, 176 Rheumatoid arthritis, 170, 290, 427, 457
Interleukin-18, 457 Nitric oxide, 33, 369, 385, 393 Rofecoxib, 154, 603
Interleukins, 265, 579 NK1 receptor antagonist, 317
Interstitial cells of Cajal, 569 NKP608, 317 Scytonemin, 112
Intra-articular injection, 357 Non-anticoagulant heparin, 435 Sensory afferents, 16
Ischemia, 435 Nonsteroidal anti-inflammatory drugs Sephadex, 144
Isolated rat uterus, 587 (NSAIDs), 51, 385, 427 Sepsis, 511
NOS, 569 Septic shock, 500
Jaundice, 511 NOS II expression, 369 Sheddase, 85
JTE-607, 160 Shedding, 83
Oedema, 236, 283 Sheep, 572
Keratinocytes, 483 ONO-4007, 38 Signal transduction, 1, 105, 119, 506
Ketoprofen, 219 Oral antigen, 206 Skin, 16
Ketoprofen lysine salt, 223 Orally active TNFalpha inhibitor, 522 Skin inflammation, 283
Kinases, 112 Osteoarthritis, 427 SOCS3, 409
Kupffer cell, 351 Outcomes, 579 Soluble HLA class I and II, 290
Oxidative stress, 351 Stabilizing action, 483
Leukotriene B4 , 144, 541 Oxygen radicals, 51 Stress, 457
Leukocyte, 182 Subepithelial fibrosis, 307
Leukocyte depletion, 363 PAI-1, 563 Substance P, 317, 393
Leukocyte recruitment, 110 Paracetamol, 219 Superoxide, 33
LFA-1, 44 Paw edema, 377 Synovium, 170
Lipid A, 357 Perfused trachea, 317
Lipocortin-1, 300 Peripheral inflammation, 16 T lymphocytes, 80
Lipopolysaccharide, 38, 409 Peritoneal macrophage, 409 T-614, 188
Liposomal Amphotericin B, 259 Peritonitis, 435 Tachyphylaxis, 587
5-Lipoxygenase, 423 Peroxynitrite, 33 TAP, 403
Liver function, 500 Picryl chloride, 444 TAqMan, 110
Liver injury, 44 Piroxicam, 219 Tea tree oil, 236, 283
Low molecular weight heparin , 182 Plasma leakage, 38, 377 Tetraploidy, 416
Lung, 63 Plasma protein exudation, 317 TGF-Beta, 307, 464
Lung epithelium, 506 Plasminogen activator inhibitor-1, 427 Th1/Th2 relationship, 80
LY293111NA, 541 Platelet aggregation inhibition, 129 Thyroid hormone, 351
Pleurisy and rat paw oedema, 603 Tissue factor, 471
Macrophages, 16, 511 PMN-Leukocytes, 557 Tissue-type plasminogen activator, 427
MAP kinases, 80, 506 Pneumonia, 265 TNF receptor, 265
Mast cells, 63, 144, 176, 259, 283, 451, Polycation, 490 TNF-alpha, 117, 176, 182, 332, 351,
611 Polyploidy, 416 500
MCP-1, 252 Potassium channel, 377 TNF-resistance, 229
Melaleuca alternifolia, 283 Potassium channel openers, 176 TNFalpha inhibitors, 522
Mesenteric traction, 495 PPAR-gamma, 58 Tolerance, 38
Metalloprotease-disintegrins, 83 Prednisolone, 457 Transcription factors, 80, 369
Metalloproteinases, 85, 170 Primary human macrophages, 403 Trinitrobenzenesulfonic acid, 444
Metamizol, 385 Procalcitonin, 265 Tyrosine kinase, 91
Major histocompatibility complex Prophylaxis, 495
(MHC), 290 Prostaglandin, 117 Ulcerative colitis, 423
Microarray technology, 403 Prostaglandin E2, 393, 541 Urokinase, 427
Microcirculation, 572 Prostaglandins, 51, 385 VEGF, 563
Microdialysis, 393 Protein ectodomain, 83 vIL-10, 342
Microvascular blood flow, 295 Pseudomonas elastase, 506 Vitamin E ointment, 483
ML3000, 129, 135 Psoriasis, 563
Monocytes, 58 Wear debris, 342
Mucin, 490 Ranitidine, 563 Wound healing, 464
Multiple organ failure, 213 RankL, 102
Multiple trauma, 265 Rat knee , 357
Muscle pain, 393 Rat paw, 295
RDP 58, 522
Nasal blockage, 206 RDP58 bioavailability and toxicity, 522
Neutrophil infiltration, 541 Receptor, 91
Neutrophils, 105, 213, 300, 324, 363, Release, 490
385, 594 Remodelling, 245
NF-kappaB, 108, 188, 357 Reperfusion injury, 435